To report long term out-comes of patients with locally advance high risk triple negative breast cancer treated with adjuvant high dose chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Study #: 1702-01
Study Status: Published
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.
Mohan M, Janz S, Brazauskas R, Dwinell MB, Teng BQ, Yun G, Dong J, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, D'Souza A.
Bone Marrow Transplantation. 2023, Aug 01: 58(8): 58(8):953-955. doi: 10.1038/s41409-023-02004-5. Epub 2023, May 06. PMCID:PMC10555486.
PMID: 37149674
Abstract